84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]李科,曹玉凈,錢亞男,等.川芎嗪對白細(xì)胞介素-1β誘導(dǎo)的軟骨細(xì)胞凋亡和氧化應(yīng)激的影響及作用機(jī)制研究[J].中醫(yī)正骨,2025,37(02):21-27.
　LI Ke,CAO Yujing,QIAN Yanan,et al.Effects and mechanism of tetramethylpyrazine on chondrocyte apoptosis and oxidative stress induced by interleukin-1β:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2025,37(02):21-27.
點(diǎn)擊復(fù)制

川芎嗪對白細(xì)胞介素-1β誘導(dǎo)的軟骨細(xì)胞凋亡和氧化應(yīng)激的影響及作用機(jī)制研究()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第37卷
期數(shù):
2025年02期
頁碼:
21-27
欄目:
基礎(chǔ)研究
出版日期:
2025-02-20

文章信息/Info

Title:
Effects and mechanism of tetramethylpyrazine on chondrocyte apoptosis and oxidative stress induced by interleukin-1β:an experimental study
作者:
李科1; 曹玉凈1; 錢亞男2; 李光輝1; 周松林1
(1.河南省中醫(yī)院,河南 鄭州 450002; 2.河南中醫(yī)藥大學(xué)骨傷學(xué)院,河南 鄭州 450002)
Author(s):
LI Ke1; CAO Yujing1; QIAN Yanan2; LI Guanghui1; ZHOU Songlin1
1.Henan Province Hospital of TCM,Zhengzhou 450002,Henan,China 2.College of Orthopaedics and Traumatology of Henan University of Chinese Medicine,Zhengzhou 450002,Henan,China
關(guān)鍵詞:
川芎嗪;  骨關(guān)節(jié)炎;  軟骨細(xì)胞;  細(xì)胞凋亡;  氧化性應(yīng)激;  白細(xì)胞介素-1β;  核轉(zhuǎn)錄因子紅系2相關(guān)因子2;  體外試驗
Keywords:
tetramethylpyrazine;  osteoarthritis;  chondrocytes;  apoptosis;  oxidative stress;  interleukin-1 beta;  nuclear factor-erythroid 2-related factor 2;  in vitro test
摘要:
目的:觀察川芎嗪(tetramethylpyrazine,TMP)對白細(xì)胞介素(interleukin,IL)-1β誘導(dǎo)的軟骨細(xì)胞凋亡和氧化應(yīng)激的影響,并探討其作用機(jī)制。方法:選用ATDC5小鼠軟骨細(xì)胞進(jìn)行實驗,加入IL-1β模擬骨關(guān)節(jié)炎環(huán)境,通過測定不同濃度TMP干預(yù)后的細(xì)胞存活率確定本實驗中TMP的濃度為5 μg·mL-1和10 μg·mL-1。將ATDC5小鼠軟骨細(xì)胞分為4組。對照組常規(guī)培養(yǎng),模型組、TMP低劑量組、TMP高劑量組均按照10 μmol·L-1加入IL-1β,TMP低劑量組、TMP高劑量組在此基礎(chǔ)上分別按照5 μg·mL-1和10 μg·mL-1加入TMP。采用CCK-8法測定細(xì)胞增殖抑制率,采用Western Blot法檢測B細(xì)胞淋巴瘤-2相關(guān)X(B-cell lymphoma-2 Associated X,Bax)蛋白含量、B細(xì)胞淋巴瘤-2(B-cell lymphoma-2,Bcl-2)蛋白含量確定細(xì)胞凋亡情況,采用ELISA測定技術(shù)檢測炎癥因子含量[IL-6、腫瘤壞死因子-α(tumor necrosis factor-α,TNF-α)],分別采用硫代巴比妥酸法、黃嘌呤氧化酶法和比色法測定丙二醛(malondialdehyde,MDA)、超氧化物歧化酶(superoxide dismutase,SOD)、谷胱甘肽(glutathione,GSH)等氧化應(yīng)激指標(biāo)含量,采用Western Blot法檢測核轉(zhuǎn)錄因子紅系2相關(guān)因子2(nuclear factor-erythroid 2-related factor 2,Nrf2)信號通路相關(guān)蛋白[Kelch樣ECH相關(guān)蛋白1(Kelch-like ECH-associated protein 1,Keap1)、Nrf2、血紅素加氧酶-1(heme oxygenase-1,HO-1)、SOD2]含量。將ATDC5小鼠軟骨細(xì)胞分為4組。空白組常規(guī)培養(yǎng); 誘導(dǎo)組按照10 μmol·L-1加入IL-1β; TMP組按照10 μmol·L-1加入 IL-1β,并按照10 μg·mL-1加入TMP; Nrf2抑制劑組先按照10 μmol·L-1加入IL-1β、按照5 μg·mL-1加入Nrf2抑制劑ML385,最后按照 10 μg·mL-1 加入TMP,采用Western Blot法檢測Nrf2下游蛋白(HO-1、SOD2)含量。結(jié)果:①軟骨細(xì)胞增殖情況檢測結(jié)果。模型組的細(xì)胞增殖抑制率高于對照組(P=0.043),TMP低劑量組和TMP高劑量組的細(xì)胞增殖抑制率均低于模型組(P=0.030,P=0.033),TMP低劑量組的細(xì)胞增殖抑制率高于TMP高劑量組(P=0.049)。②軟骨細(xì)胞凋亡情況檢測結(jié)果。模型組的Bax/Bcl-2蛋白含量比值高于對照組、TMP低劑量組及TMP高劑量組(P=0.000,P=0.005,P=0.000),TMP高劑量組的Bax/Bcl-2蛋白含量比值低于TMP低劑量組(P=0.003)。③軟骨細(xì)胞中炎癥因子含量檢測結(jié)果。模型組的IL-6和TNF-α含量均高于對照組、TMP低劑量組及TMP高劑量組(IL-6:P=0.035,P=0.024,P=0.049; TNF-α:P=0.017,P=0.039,P=0.032); TMP低劑量組的IL-6和TNF-α含量均高于TMP高劑量組(P=0.019,P=0.028)。④軟骨細(xì)胞中氧化應(yīng)激指標(biāo)含量檢測結(jié)果。模型組的MDA含量高于對照組(P=0.027),SOD和GSH含量均低于對照組(P=0.013,P=0.028); TMP低劑量組和TMP高劑量組的MDA含量均低于模型組(P=0.020,P=0.040),SOD和GSH含量均高于模型組(SOD:P=0.048,P=0.039; GSH:P=0.031,P=0.022); TMP高劑量組的MDA含量低于TMP低劑量組(P=0.040),SOD和GSH含量均高于TMP低劑量組(P=0.026,P=0.038)。⑤軟骨細(xì)胞中Nrf2信號通路相關(guān)蛋白含量檢測結(jié)果。模型組的Keap1蛋白含量高于對照組(P=0.000),Nrf2、HO-1及SOD2蛋白含量均低于對照組(P=0.003,P=0.004,P=0.003); TMP低劑量組和TMP高劑量組的Keap1蛋白含量均低于模型組(P=0.002,P=0.000),Nrf2、HO-1及SOD2蛋白含量均高于模型組(Nrf2:P=0.002,P=0.008; HO-1:P=0.000,P=0.001; SOD2:P=0.002,P=0.000); TMP高劑量組的Keap1蛋白含量低于TMP低劑量組(P=0.034),Nrf2、HO-1及SOD2蛋白含量均高于TMP低劑量組(P=0.000,P=0.039,P=0.029)。⑥Nrf2抑制劑干預(yù)后軟骨細(xì)胞中Nrf2下游蛋白含量測定結(jié)果。誘導(dǎo)組的HO-1、SOD2蛋白含量均低于空白組(P=0.000,P=0.001),TMP組的HO-1、SOD2蛋白含量均高于誘導(dǎo)組(P=0.023,P=0.030),Nrf2抑制劑組的HO-1、SOD2蛋白含量均低于TMP組(P=0.040,P=0.000)。結(jié)論:TMP對IL-1β誘導(dǎo)的軟骨細(xì)胞凋亡和氧化應(yīng)激具有保護(hù)作用,其作用機(jī)制可能與激活Nrf2信號通路,增強(qiáng)軟骨細(xì)胞抗氧化能力有關(guān)。
Abstract:
Objective:To observe the effects of tetramethylpyrazine(TMP)on interleukin(IL)-1β-induced chondrocyte apoptosis and oxidative stress,and to explore its underlying mechanism.Methods:The ATDC5 mouse chondrocytes(ATDC5 cells)were selected and cultured in the Dulbecco's Modified Eagle's Medium(DMEM)added with IL-1β aimed at simulating the environment of osteoarthritis.The concentrations of TMP for the following experiment were determined to be 5 and 10 μg/mL by measuring the cell survival rate after intervention with different concentrations of TMP.The ATDC5 cells were divided into control group,model group,low-dose TMP(L-TMP)group,and high-dose TMP(H-TMP)group.The ATDC5 cells in the control group were cultured in the conventional DMEM; while the ones in mo-del group,L-TMP group,and H-TMP group in the DMEM adding with IL-1β with concentration of 10 ng/mL; and the DMEM in L-TMP group and H-TMP group were further added with TMP with concentration of 5 and 10 μg/mL,respectively.After 24-hour culture,the pro-liferation inhibition rate of the ATDC5 cells in each group was determined by using the cell counting kit-8(CCK-8)assay; the levels of B-cell lymphoma-2 Associated X(Bax)protein and B-cell lymphoma-2(Bcl-2)protein in the ATDC5 cells were detected by using Western blotting to determine the cellular apoptosis; the levels of inflammatory cytokines including IL-6 and tumor necrosis factor-α( TNF-α)in the ATDC5 cells were detected by using enzyme-linked immunosorbent assay(ELISA); the levels of oxidative stress markers including malondialdehyde(MDA),superoxide dismutase(SOD),and glutathione(GSH)in the ATDC5 cells were determined by using the thiobarbituric acid(TBA)method,xanthine oxidase(XO)method,and colorimetry,respectively; and the levels of nuclear factor-erythroid 2-related factor 2(Nrf2)signaling pathway-related proteins including Kelch-like ECH-associated protein 1(Keap1),Nrf2,heme oxygenase-1(HO-1),and SOD2 in the ATDC5 cells were detected by using Western blotting.Furthermore,another ATDC5 cells were divided into blank group,induction group,TMP group,and Nrf2 inhibitor group.The ATDC5 cells in the blank group were cultured in the conventional DMEM; while the ones in induction group in the DMEM adding with IL-1β with concentration of 10 μmol/L; the ones in TMP group in the DMEM adding with IL-1β with concentration of 10 μmol/L and TMP with concentration of 10 μg/mL; and the ones in Nrf2 inhibitor group in the DMEM adding with IL-1β with concentration of 10 μmol/L,ML385 with concentration of 5 μg/mL and TMP with concentration of 10 μg/mL.The levels of Nrf2 downstream proteins including HO-1 and SOD2 in the ATDC5 cells were detected by employing Western blotting.Results:①The proliferation of the ATDC5 cells.The proliferation inhibition rate of the ATDC5 cells was higher in model group compared to control group(P=0.043),and was lower in L-TMP group and H-TMP group compared to model group(P=0.030,P=0.033),and was higher in L-TMP group compared to H-TMP group(P=0.049).②The apoptosis of the ATDC5 cells.The ratio of Bax protein level to Bcl-2 protein level was greater in model group compared to control group,L-TMP group and H-TMP group(P=0.000,P=0.005,P=0.000),and was smaller in H-TMP group compared to L-TMP group(P=0.003).③The levels of inflammatory cytokines in the ATDC5 cells.The levels of IL-6 and TNF-α in the ATDC5 cells were higher in model group compared to control group,L-TMP group and H-TMP group(IL-6:P=0.035,P=0.024,P=0.049; TNF-α:P=0.017,P=0.039,P=0.032),and were higher in L-TMP group compared to H-TMP group(P=0.019,P=0.028).④The levels of oxidative stress markers in the ATDC5 cells.The level of MDA was higher,while the levels of SOD and GSH were lower in model group compared to control group(P=0.027,P=0.013,P=0.028).The level of MDA was lower,while the levels of SOD and GSH were higher in L-TMP group and H-TMP group compared to model group(MDA:P=0.020,P=0.040; SOD:P=0.048,P=0.039; GSH:P=0.031,P=0.022).The level of MDA was lower,while the levels of SOD and GSH were higher in H-TMP group compared to L-TMP group(P=0.040,P=0.026,P=0.038).⑤The levels of Nrf2 signaling pathway-related proteins in the ATDC5 cells.The level of Keap1 was higher,while the levels of Nrf2,HO-1 and SOD2 were lower in model group compared to control group(P=0.000,P=0.003,P=0.004,P=0.003).The level of Keap1 was lower,while the levels of Nrf2,HO-1 and SOD2 were higher in L-TMP group and H-TMP group compared to model group(Keap1:P=0.002,P=0.000; Nrf2:P=0.002,P=0.008; HO-1:P=0.000,P=0.001; SOD2:P=0.002,P=0.000).The level of Keap1 was lower,while the levels of Nrf2,HO-1 and SOD2 were higher in H-TMP group compared to L-TMP group(P=0.034,P=0.000,P=0.039,P=0.029).⑥The levels of Nrf2 downstream proteins in the ATDC5 cells after intervention with inhibitor.The levels of HO-1 and SOD2 in the ATDC5 cells were lower in induction group compared to blank group(P=0.000,P=0.001),and were higher in TMP group compared to induction group(P=0.023,P=0.030),and were lower in Nrf2 inhibitor group compared to TMP group(P=0.040,P=0.000).Conclusion:TMP has a protective effect against chondrocyte apoptosis and oxidative stress induced by IL-1β.It may exert the effects by activating Nrf2 signaling pathway and enhancing the antioxidant capacity of chondrocytes.

參考文獻(xiàn)/References:

[1] ABRAMOFF B,CALDERA F E.Osteoarthritis:pathology,diagnosis,and treatment options[J].Med Clin North Am,2020,104(2):293-311.
[2] CHO Y,JEONG S,KIM H,et al.Disease-modifying therapeutic strategies in osteoarthritis:current status and future directions[J].EXP MOL MED,2021,53(11):1689-1696.
[3] ECCLESTON A.Cartilage regeneration for osteoarthri-tis[J].Nat Rev Drug Discov,2023,22(2):96.
[4] ZENG C Y,WANG X F,HUA F Z.HIF-1α in osteoarthritis:from pathogenesis to therapeutic implications[J].Front Pharmacol,2022,13:927126.
[5] MAO L,WU W,WANG M,et al.Targeted treatment for osteoarthritis:drugs and delivery system[J].Drug Deliv,2021,28(1):1861-1876.
[6] WOLFF D G,CHRISTOPHERSEN C,BROWN S M,et al.Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis:a systematic review and meta-analysis[J].Phys Sportsmed,2021,49(4):381-391.
[7] CHANG M C,CHIANG P F,KUO Y J,et al.Hyaluronan-loaded liposomal dexamethasone-diclofenac nanoparticles for local osteoarthritis treatment[J].Int J Mol Sci,2021,22(2):665.
[8] HU P Y,YUE P F,ZHENG Q,et al.Pharmacokinetic comparative study of gastrodin after oral administration of gastrodia elata Bl. extract and its compatibility with the different indigents of ligusticum chuanxiong Hort. to rats[J].J Ethnopharmacol,2016,191:82-86.
[9] ZHANG K,FANG K L,WANG T,et al.Chemical constituents from the rhizome of ligusticum chuanxiong hort.and their Nrf2 inducing activity[J].Chem Biodivers,2021,18(11):e2100302.
[10] DONKOR P O,CHEN Y,DING L,et al.Locally and traditionally used ligusticum species—a review of their phytochemistry,pharmacology and pharmacokinetics[J].J Ethnopharmacol,2016,194:530-548.
[11] BAI Y,WEI W,YAO C,et al.Advances in the chemical constituents,pharmacological properties and clinical applications of TCM formula Yupingfeng San[J].Fitoterapia,2023,164:105385.
[12] HU S,WANG S,HE J,et al.Tetramethylpyrazine alleviates endoplasmic reticulum stress activated apoptosis and related inflammation in chondrocytes[J].Mol Med Rep,2022,25(1):12.
[13] ZHANG X,SHI Y,ZHANG Z,et al.Intra-articular delivery of tetramethylpyrazine microspheres with enhanced articular cavity retention for treating osteoarthritis[J].Asian J Pharm Sci,2018,13(3):229-238.
[14] HUANG Y F,WANG G,DING L,et al.Lactate-upregulated NADPH-dependent NOX4 expression via HCAR1/PI3K pathway contributes to ROS-induced osteoarthritis chondrocyte damage[J].Redox Biol,2023,67:102867.
[15] DING D F,XUE Y,WU X C,et al.Recent Advances in reactive oxygen species(ROS)-responsive polyfunctional nanosystems 3.0 for the treatment of osteoarthritis[J].J Inflamm Res,2022,15:5009-5026.
[16] PARK W H.Effects of antioxidants and MAPK inhibitors on cell death and reactive oxygen species levels in H(2)O(2)-treated human pulmonary fibroblasts[J].Oncol Lett,2013,5(5):1633-1638.
[17] WU Y,JIA C,LIU W,et al.Sodium citrate targeting Ca(2+)/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer[J].J Adv Res,2024,65:89-104.
[18] ARRA M,SWARNKAR G,KE K,et al.LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis[J].Nat Commun,2020,11(1):3427.
[19] ISHII T,ITOH K,TAKAHASHI S,et al.Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages[J].J Biol Chem,2000,275(21):16023-16029.
[20] DONG Y,KANG H,PENG R,et al.A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis[J].Cell Metab,2024,36(8):1679-1695.

相似文獻(xiàn)/References:

[1]樊慶陽,任凱晶.定制3D打印切模輔助全膝關(guān)節(jié)置換術(shù)治療 膝骨關(guān)節(jié)炎合并股骨干骨折畸形愈合[J].中醫(yī)正骨,2015,27(11):37.
[2]應(yīng)俊,張元斌,羅程,等.核轉(zhuǎn)錄因子-κB在骨關(guān)節(jié)炎炎癥反應(yīng)中的作用[J].中醫(yī)正骨,2015,27(07):40.
[3]馮榮,王平,李炳奇,等.鈹針刺絡(luò)拔罐結(jié)合中藥口服治療膝骨關(guān)節(jié)炎合并 原發(fā)性血小板增多癥1例[J].中醫(yī)正骨,2015,27(12):73.
[4]高寧陽,丁立,龐堅,等.miRNAs與骨關(guān)節(jié)炎關(guān)系的研究進(jìn)展[J].中醫(yī)正骨,2015,27(12):74.
[5]蔡云仙.圍手術(shù)期耳穴按壓聯(lián)合平衡針療法 在全膝關(guān)節(jié)置換術(shù)后鎮(zhèn)痛中的應(yīng)用[J].中醫(yī)正骨,2015,27(06):41.
[6]魏瑄,宋樹春,王金良.術(shù)前精確測量和評估在全髖關(guān)節(jié)置換治療 成人發(fā)育性髖關(guān)節(jié)發(fā)育不良繼發(fā)骨關(guān)節(jié)炎中的價值[J].中醫(yī)正骨,2015,27(01):30.
[7]李顯,顧敏琪.蜂毒與蜂針療法的作用機(jī)制及其在類風(fēng)濕關(guān)節(jié)炎 和骨關(guān)節(jié)炎治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(02):69.
[8]劉飛,劉剛,郭浩山,等.化瘀滲濕湯對全膝關(guān)節(jié)置換術(shù)后血漿D-二聚體 和纖維蛋白原含量的影響[J].中醫(yī)正骨,2016,28(03):30.
　LIU Fei,LIU Gang,GUO Haoshan,et al.Effect of Huayu Shenshi Tang(化瘀滲濕湯)on plasma contents of D-dimer and fibrinogen after total knee arthroplasty[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):30.
[9]趙明明,蔡一強(qiáng),丁永利,等.無柄人工全髖關(guān)節(jié)置換術(shù)治療髖關(guān)節(jié)疾患的臨床研究[J].中醫(yī)正骨,2016,28(04):37.
[10]徐方琪,孫奇,朱星瑜,等.不同生理磁共振成像技術(shù)在早期膝骨關(guān)節(jié)炎診斷中的應(yīng)用進(jìn)展[J].中醫(yī)正骨,2016,28(04):64.

備注/Memo

備注/Memo:
基金項目:河南省中醫(yī)藥科學(xué)研究專項課題(2024ZYZD06,2023ZY1008,2019ZYBJ15)
通訊作者:曹玉凈 E-mail:[email protected]
更新日期/Last Update: 1900-01-01